Celgene's distribution plans

BETHESDA, Md. - If and when FDA approves thalidomide, it is likely to be the first drug to have mandatory distribution restrictions imposed on it to prevent fetal exposure. Other teratogens have been approved on the basis of voluntary restrictions.

Celgene Corp. last week described proposed controls on its thalidomide that would include mandatory counseling about the risks and benefits for